CompletedNCT05449717

Incidence of Relapse and Post-Kala-Azar Dermal Leishmaniasis in South Sudan

Studying Leishmaniasis

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Epicentre
Principal Investigator
Rebecca M Coulborn, MPH
Epicentre
Enrollment
52 enrolled
Eligibility
All sexes
Timeline
2022 – 2025

Study locations (1)

Collaborators

European and Developing Countries Clinical Trials Partnership (EDCTP) · Drugs for Neglected Diseases · Medecins Sans Frontieres, Netherlands

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT05449717 on ClinicalTrials.gov

Other trials for Leishmaniasis

Additional recruiting or active studies for the same condition.

See all trials for Leishmaniasis →

← Back to all trials